AI assistant
Sending…
AtriCure, Inc. — Director's Dealing 2018
Jan 8, 2018
31802_dirs_2018-01-08_97a74eab-2815-4b77-89bc-29f67b244c79.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2017-12-29
Reporting Person: CARREL MICHAEL H (Director, President, CEO, & Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-29 | Common Stock | A | 547 | $15.50 | Acquired | 669843 | Direct |
Footnotes
F1: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 31, 2017.
F2: Closing price on December 29, 2017 was $18.24.
More from AtriCure, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3